ICPT
Intercept Pharmaceuticals, Inc. (ICPT)
$13.99
Market is closedMarket is closed – opens on 8 PM, 07 Dec 2022
– opens on 8 PM, 07 Dec 2022
Key Stats
$13.85
Day's Range
$14.38
$10.81
52-Week Range
$21.25
| Returns | |
| 1 month return | 8.68% |
| 3 month return | 16.78% |
| 1 year return | 17.46% |
| 5 year return | 77.24% |
Company Information
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada.
| Organization | Intercept Pharmaceuticals, Inc. |
| Employees | 437 |
| CEO | Mr. Jerome B. Durso |
| Industry | Health Technology |
Analyst Recommendation
based on 18 analysts ratings
Hold
22%
Buy
66%
Hold
11%
Sell
Based on 18 Wall street analysts offering stock ratings for Intercept Pharmaceuticals, Inc.(by analysts ranked 0 to 5 stars)
Analyst Forecast
What analysts predicted
Upside of 63.4%Current
$13.99
Target
$22.86
Recommendation Trend
Based on 18 analyst
| Current | 1M Ago | 3M Ago | |
| Buy | 4 | 10 | 10 |
| Hold | 12 | 10 | 10 |
| Sell | 2 | 2 | 2 |
| Consensus | HOLD | BUY | BUY |
Company Financials
Highlights
| Market Capitalization | 593.1M |
| Book Value | $2.6 |
| Dividend Share | 0.0 |
| Dividend Yield | 0.0% |
| Earnings Per Share (EPS) | -2.2 |
| PEG Ratio | -0.69 |
| Wall Street Target Price | 22.86 |
Valuation
| Trailing PE | 0.0 |
| Forward PE | 7.99 |
| Price/Book (mrq) | 5.62 |
| Enterprise Value | 447.0M |
| Enterprise Value/Revenue | 1.18 |
| Enterprise Value/Ebitda | -3.57 |
Technicals
| Beta | 1.14 |
| 50 Day MA | 14.6 |
| 200 Day MA | 15.6 |
Institutional Holdings
State Street Corporation
7.37%
BlackRock Inc
7.09%
Vanguard Group Inc
6.53%
FMR Inc
4.99%
Point72 Asset Management, L.P.
3.76%
Morgan Stanley - Brokerage Accounts
2.17%
Discover more
Frequently Asked Questions
What is Intercept Pharmaceuticals, Inc. share price today?
Can Indians buy Intercept Pharmaceuticals, Inc. shares?
How can I buy Intercept Pharmaceuticals, Inc. shares from India?
Can Fractional shares of Intercept Pharmaceuticals, Inc. be purchased?
What are the documents required to start investing in Intercept Pharmaceuticals, Inc. stocks?
What are today’s High and Low prices of Intercept Pharmaceuticals, Inc.?
What are today’s traded volumes of Intercept Pharmaceuticals, Inc.?
What is today’s market capitalisation of Intercept Pharmaceuticals, Inc.?
What is the 52 Week High and Low Range of Intercept Pharmaceuticals, Inc.?
How much percentage Intercept Pharmaceuticals, Inc. is down from its 52 Week High?
How much percentage Intercept Pharmaceuticals, Inc. is up from its 52 Week low?
What are the historical returns of Intercept Pharmaceuticals, Inc.?
Who is the Chief Executive Officer (CEO) of Intercept Pharmaceuticals, Inc.?
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*